Advertisement

Regulation of Circadian Genes by the MAPK Pathway: Implications for Rapid Antidepressant Action

  • Xin-Ling Wang
  • Kai Yuan
  • Wen Zhang
  • Su-Xia LiEmail author
  • George Fu GaoEmail author
  • Lin LuEmail author
Review
  • 75 Downloads

Abstract

Accumulating evidence suggests that the circadian rhythm plays a critical role in mood regulation, and circadian disturbances are often found in patients with major depressive disorder (MDD). The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway is involved in mediating entrainment of the circadian system. Furthermore, the MAPK/ERK signaling pathway has been shown to be involved in the pathogenesis of MDD and the rapid onset of action of antidepressant therapies, both pharmaceutical and non-pharmaceutical. This review provides an overview of the involvement of the MAPK/ERK pathway in modulating the circadian system in the rapid action of antidepressant therapies. This pathway holds much promise for the development of novel, rapid-onset-of-action therapeutics for MDD.

Keywords

Major depressive disorder MAPK pathway Circadian system Rapid antidepressant therapy 

Notes

Acknowledgements

This review was supported by the National Basic Research Development Program of China (2015CB856400 and 2015CB553503), the National Natural Science Foundation of China (81521063), and the Natural Science Foundation of Beijing Municipality, China (7162101).

References

  1. 1.
    Albrecht U. Molecular mechanisms in mood regulation involving the circadian clock. Frontiers In Neurology 2017,8.Google Scholar
  2. 2.
    McClung CA. How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry 2013,74:242–249.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry 2015,20:48–55.CrossRefPubMedGoogle Scholar
  4. 4.
    Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 2007,61:661–670.CrossRefPubMedGoogle Scholar
  5. 5.
    Serchov T, Heumann R. Ras activity tunes the period and modulates the entrainment of the suprachiasmatic clock. Frontiers In Neurology 2017,8.Google Scholar
  6. 6.
    Goldsmith CS, Bell-Pedersen D. Diverse roles for MAPK signaling in circadian clocks. Adv Genet 2013,84:1–39.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bunney BG, Bunney WE. Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiatry 2013,73:1164–1171.CrossRefPubMedGoogle Scholar
  8. 8.
    Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 2012,35:445–462.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Zhang EE, Kay SA. Clocks not winding down: unravelling circadian networks. Nat Rev Mol Cell Biol 2010,11:764–776.CrossRefPubMedGoogle Scholar
  10. 10.
    Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, et al. Interacting molecular loops in the mammalian circadian clock. Science 2000,288:1013–1019.CrossRefPubMedGoogle Scholar
  11. 11.
    Honma S, Ikeda M, Abe H, Tanahashi Y, Namihira M, Honma K, et al. Circadian oscillation of BMAL1, a partner of a mammalian clock gene Clock, in rat suprachiasmatic nucleus. Biochem Biophys Res Commun 1998,250:83–87.CrossRefPubMedGoogle Scholar
  12. 12.
    Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004,43:527–537.CrossRefPubMedGoogle Scholar
  13. 13.
    Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002,110:251–260.CrossRefPubMedGoogle Scholar
  14. 14.
    Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 2002,419:841–844.CrossRefPubMedGoogle Scholar
  15. 15.
    Ueda HR, Hayashi S, Chen W, Sano M, Machida M, Shigeyoshi Y, et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet 2005,37:187–192.CrossRefPubMedGoogle Scholar
  16. 16.
    Bunney WE, Bunney BG. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 2000,22:335–345.CrossRefPubMedGoogle Scholar
  17. 17.
    Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 2001,63:647–676.CrossRefPubMedGoogle Scholar
  18. 18.
    Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006,21 Suppl 1:S11–15.CrossRefPubMedGoogle Scholar
  19. 19.
    McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007,114:222–232.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ehlers CL, Frank E, Kupfer DJ. Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Arch Gen Psychiatry 1988,45:948–952.Google Scholar
  21. 21.
    Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT, et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 2013,38:2789–2799.CrossRefPubMedGoogle Scholar
  22. 22.
    Logan RW, Edgar N, Gillman AG, Hoffman D, Zhu XY, McClung CA. Chronic stress induces brain region-specific alterations of molecular rhythms that correlate with depression-like behavior in mice. Biol Psychiatry 2015,78:249–258.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zhao Y, Liu LJ, Wang C, Li SX. Swimming exercise may not alleviate the depressive-like behaviors and circadian alterations of neuroendocrine induced by chronic unpredictable mild stress in rats. Neurol, Pychiatry Brain Res 2012,18:202–207.CrossRefGoogle Scholar
  24. 24.
    Guo TY, Liu LJ, Xu LZ, Zhang JC, Li SX, Chen C, et al. Alterations of the daily rhythms of HPT axis induced by chronic unpredicted mild stress in rats. Endocrine 2015,48:637–643.CrossRefPubMedGoogle Scholar
  25. 25.
    Jiang WG, Li SX, Zhou SJ, Sun Y, Shi J, Lu L. Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus. Brain Res 2011,1399:25–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Jiang WG, Li SX, Liu JF, Sun Y, Zhou SJ, Zhu WL, et al. Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress. Psychopharmacology (Berl) 2013,227:79–92.CrossRefGoogle Scholar
  27. 27.
    Partonen T. Clock gene variants in mood and anxiety disorders. J Neural Transm (Vienna) 2012,119:1133–1145.CrossRefGoogle Scholar
  28. 28.
    McClung CA. Circadian rhythms and mood regulation: insights from pre-clinical models. Eur Neuropsychopharmacol 2011,21 Suppl 4:S683–693.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 2007,104:6406–6411.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hampp G, Albrecht U. The circadian clock and mood-related behavior. Commun Integr Biol 2008,1:1–3.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 2008,18:678–683.CrossRefPubMedGoogle Scholar
  32. 32.
    Spulber S, Conti M, DuPont C, Raciti M, Bose R, Onishchenko N, et al. Alterations in circadian entrainment precede the onset of depression-like behavior that does not respond to fluoxetine. Transl Psychiatry 2015,5:e603.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Wright KP, Jr., Czeisler CA. Absence of circadian phase resetting in response to bright light behind the knees. Science 2002,297:571.CrossRefPubMedGoogle Scholar
  34. 34.
    Honma S. The mammalian circadian system: a hierarchical multi-oscillator structure for generating circadian rhythm. J Physiol Sci 2018,68:207–219.CrossRefPubMedGoogle Scholar
  35. 35.
    Zeitzer JM, Kronauer RE, Czeisler CA. Photopic transduction implicated in human circadian entrainment. Neurosci Lett 1997,232:135–138.CrossRefPubMedGoogle Scholar
  36. 36.
    Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000,526 Pt 3:695–702.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Duffy JF, Wright KP, Jr. Entrainment of the human circadian system by light. J Biol Rhythms 2005,20:326–338.CrossRefPubMedGoogle Scholar
  38. 38.
    Akashi M, Nishida E. Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes & Development 2000,14:645–649.Google Scholar
  39. 39.
    Plotnikov A, Zehorai E, Procaccia S, Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 2011,1813:1619–1633.CrossRefPubMedGoogle Scholar
  40. 40.
    Serchov T, Jilg A, Wolf CT, Radtke I, Stehle JH, Heumann R. Ras activity oscillates in the mouse suprachiasmatic nucleus and modulates circadian clock dynamics. Mol Neurobiol 2016,53:1843–1855.CrossRefPubMedGoogle Scholar
  41. 41.
    Butcher GQ, Lee B, Obrietan K. Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus. J Neurophysiol 2003,90:3854–3863.CrossRefPubMedGoogle Scholar
  42. 42.
    Cheng P, He Q, He Q, Wang L, Liu Y. Regulation of the Neurospora circadian clock by an RNA helicase. Genes Dev 2005,19:234–241.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Eckel-Mahan KL, Phan T, Han S, Wang H, Chan GC, Scheiner ZS, et al. Circadian oscillation of hippocampal MAPK activity and cAMP: implications for memory persistence. Nat Neurosci 2008,11:1074–1082.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Hayashi Y, Sanada K, Fukada Y. Circadian and photic regulation of MAP kinase by Ras- and protein phosphatase-dependent pathways in the chick pineal gland. FEBS Lett 2001,491:71–75.CrossRefPubMedGoogle Scholar
  45. 45.
    Relogio A, Thomas P, Medina-Perez P, Reischl S, Bervoets S, Gloc E, et al. Ras-mediated deregulation of the circadian clock in cancer. PLoS Genet 2014,10:e1004338.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Serchov T, Heumann R. Constitutive activation of ras in neurons: implications for the regulation of the mammalian circadian clock. Chronobiol Int 2006,23:191–200.CrossRefPubMedGoogle Scholar
  47. 47.
    Tsuchiya Y, Minami I, Kadotani H, Todo T, Nishida E. Circadian clock-controlled diurnal oscillation of Ras/ERK signaling in mouse liver. Proc Jpn Acad Ser B Phys Biol Sci 2013,89:59–65.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Weber F, Hung HC, Maurer C, Kay SA. Second messenger and Ras/MAPK signalling pathways regulate CLOCK/CYCLE-dependent transcription. J Neurochem 2006,98:248–257.CrossRefPubMedGoogle Scholar
  49. 49.
    Butcher GQ, Doner J, Dziema H, Collamore M, Burgoon PW, Obrietan K. The p42/44 mitogen-activated protein kinase pathway couples photic input to circadian clock entrainment. J Biol Chem 2002,277:29519–29525.CrossRefPubMedGoogle Scholar
  50. 50.
    Coogan AN, Piggins HD. MAP kinases in the mammalian circadian system–key regulators of clock function. J Neurochem 2004,90:769–775.CrossRefPubMedGoogle Scholar
  51. 51.
    Schmidt TM, Chen SK, Hattar S. Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends Neurosci 2011,34:572–580.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010,72:517–549.CrossRefPubMedGoogle Scholar
  53. 53.
    Tischkau SA, Gallman EA, Buchanan GF, Gillette MU. Differential cAMP gating of glutamatergic signaling regulates long-term state changes in the suprachiasmatic circadian clock. J Neurosci 2000,20:7830–7837.CrossRefPubMedGoogle Scholar
  54. 54.
    Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock - mediation of nocturnal circadian shifts by glutamate and No. Science 1994,266:1713–1717.CrossRefPubMedGoogle Scholar
  55. 55.
    Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA. Calcium Activation Of Ras Mediated by Neuronal Exchange Factor Ras-Grf. Nature 1995,376:524–527.CrossRefPubMedGoogle Scholar
  56. 56.
    Wang JQ, Tang QS, Parelkar NK, Liu ZG, Samdani S, Choe ES, et al. Glutamate signaling to Ras-MAPK in striatal neurons - Mechanisms for inducible gene expression and plasticity. Mol Neurobiol 2004,29:1–14.CrossRefPubMedGoogle Scholar
  57. 57.
    Butcher GQ, Lee BY, Hsieh F, Obrietan K. Light- and clock-dependent regulation of ribosomal S6 kinase activity in the suprachiasmatic nucleus. Eur J Neurosci 2004,19:907–915.CrossRefPubMedGoogle Scholar
  58. 58.
    Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci U S A 2002,99:7728–7733.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Eiden LE, Emery AC, Zhang LM, Smith CB. PACAP signaling in stress: insights from the chromaffin cell. Pflugers Arch 2018,470:79–88.CrossRefPubMedGoogle Scholar
  60. 60.
    Dziema H, Oatis B, Butcher GQ, Yates R, Hoyt KR, Obrietan K. The ERK/MAP kinase pathway couples light to immediate-early gene expression in the suprachiasmatic nucleus. Eur J Neurosci 2003,17:1617–1627.CrossRefPubMedGoogle Scholar
  61. 61.
    Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 1990,5:127–134.CrossRefPubMedGoogle Scholar
  62. 62.
    Abe H, Rusak B. Physiological mechanisms regulating photic induction of Fos-like protein in hamster suprachiasmatic nucleus. Neurosci Biobehav Rev 1994,18:531–536.CrossRefPubMedGoogle Scholar
  63. 63.
    Tischkau SA, Mitchell JW, Tyan SH, Buchanan GF, Gillette MU. Ca2+/cAMP response element-binding protein (CREB)-dependent activation of Per1 is required for light-induced signaling in the suprachiasmatic nucleus circadian clock. J Biol Chem 2003,278:718–723.CrossRefPubMedGoogle Scholar
  64. 64.
    Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004,68:320–344.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Mrosovsky N. A non-photic gateway to the circadian clock of hamsters. Ciba Found Symp 1995,183:154–167; discussion 167–174.Google Scholar
  66. 66.
    Mrosovsky N. Locomotor activity and non-photic influences on circadian clocks. Biol Rev Camb Philos Soc 1996,71:343–372.CrossRefPubMedGoogle Scholar
  67. 67.
    Antle MC, Tse F, Koke SJ, Sterniczuk R, Hagel K. Non-photic phase shifting of the circadian clock: role of the extracellular signal-responsive kinases I/II/mitogen-activated protein kinase pathway. Eur J Neurosci 2008,28:2511–2518.CrossRefPubMedGoogle Scholar
  68. 68.
    Van Reeth O, Turek FW. Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines. Nature 1989,339:49–51.CrossRefPubMedGoogle Scholar
  69. 69.
    Mrosovsky N, Salmon PA. Triazolam and phase-shifting acceleration re-evaluated. Chronobiol Int 1990,7:35–41.CrossRefPubMedGoogle Scholar
  70. 70.
    Marchant EG, Mistlberger RE. Morphine phase-shifts circadian rhythms in mice: role of behavioural activation. Neuroreport 1995,7:209–212.PubMedGoogle Scholar
  71. 71.
    Reebs SG, Mrosovsky N. Effects of induced wheel running on the circadian activity rhythms of Syrian hamsters: entrainment and phase response curve. J Biol Rhythms 1989,4:39–48.CrossRefPubMedGoogle Scholar
  72. 72.
    Wickland CR, Turek FW. Phase-shifting effects of acute increases in activity on circadian locomotor rhythms in hamsters. Am J Physiol 1991,261:R1109–1117.PubMedGoogle Scholar
  73. 73.
    Mrosovsky N. Phase response curves for social entrainment. J Comp Physiol A 1988,162:35–46.CrossRefPubMedGoogle Scholar
  74. 74.
    Antle MC, Mistlberger RE. Circadian clock resetting by sleep deprivation without exercise in the Syrian hamster. J Neurosci 2000,20:9326–9332.CrossRefPubMedGoogle Scholar
  75. 75.
    Mistlberger RE, Skene DJ. Nonphotic entrainment in humans? J Biol Rhythms 2005,20:339–352.CrossRefPubMedGoogle Scholar
  76. 76.
    Coogan AN, Piggins HD. Dark pulse suppression of P-ERK and c-Fos in the hamster suprachiasmatic nuclei. Eur J Neurosci 2005,22:158–168.CrossRefPubMedGoogle Scholar
  77. 77.
    van Calker D, Biber K. The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders. Neurochem Res 2005,30:1205–1217.CrossRefPubMedGoogle Scholar
  78. 78.
    Burnstock G, Krugel U, Abbracchio MP, Illes P. Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 2011,95:229–274.CrossRefPubMedGoogle Scholar
  79. 79.
    Sadek AR, Knight GE, Burnstock G. Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling. Purinergic Signal 2011,7:447–452.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Serchov T, Heumann R, van Calker D, Biber K. Signaling pathways regulating Homer1a expression: implications for antidepressant therapy. Biol Chem 2016,397:207–214.CrossRefPubMedGoogle Scholar
  81. 81.
    Basheer R, Bauer A, Elmenhorst D, Ramesh V, McCarley RW. Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport 2007,18:1895–1899.CrossRefPubMedGoogle Scholar
  82. 82.
    Elmenhorst D, Basheer R, McCarley RW, Bauer A. Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res 2009,1258:53–58.CrossRefPubMedGoogle Scholar
  83. 83.
    Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, et al. Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J Neurosci 2007,27:2410–2415.CrossRefPubMedGoogle Scholar
  84. 84.
    Bekar L, Libionka W, Tian GF, Xu Q, Torres A, Wang X, et al. Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat Med 2008,14:75–80.CrossRefPubMedGoogle Scholar
  85. 85.
    Hamani C, Diwan M, Macedo CE, Brandao ML, Shumake J, Gonzalez-Lima F, et al. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 2010,67:117–124.CrossRefPubMedGoogle Scholar
  86. 86.
    Biber K, Klotz KN, Berger M, Gebicke-Harter PJ, van Calker D. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 1997,17:4956–4964.CrossRefPubMedGoogle Scholar
  87. 87.
    Rogel A, Bromberg Y, Sperling O, Zoref-Shani E. The neuroprotective adenosine-activated signal transduction pathway involves activation of phospholipase C. Nucleosides Nucleotides Nucleic Acids 2006,25:1283–1286.CrossRefPubMedGoogle Scholar
  88. 88.
    Fenton RA, Shea LG, Doddi C, Dobson JG, Jr. Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27. Am J Physiol Heart Circ Physiol 2010,298:H1671–1678.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Robin E, Sabourin J, Benoit R, Pedretti S, Raddatz E. Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK- and PLC/PKC-dependent mechanisms. J Mol Cell Cardiol 2011,51:945–954.CrossRefPubMedGoogle Scholar
  90. 90.
    Migita H, Kominami K, Higashida M, Maruyama R, Tuchida N, McDonald F, et al. Activation of adenosine A1 receptor-induced neural stem cell proliferation via MEK/ERK and Akt signaling pathways. J Neurosci Res 2008,86:2820–2828.CrossRefPubMedGoogle Scholar
  91. 91.
    Kunduri SS, Mustafa SJ, Ponnoth DS, Dick GM, Nayeem MA. Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-alpha, and ERK1/2. J Cardiovasc Pharmacol 2013,62:78–83.CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P, et al. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology 2009,56:37–46.CrossRefPubMedGoogle Scholar
  93. 93.
    Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, Simen AA, et al. A negative regulator of MAP kinase causes depressive behavior. Nat Med 2010,16:1328–1332.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Zhang L, Xu T, Wang S, Yu L, Liu D, Zhan R, et al. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice. Behav Brain Res 2012,235:67–72.CrossRefPubMedGoogle Scholar
  95. 95.
    Di Benedetto B, Radecke J, Schmidt MV, Rupprecht R. Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex. Neuroscience 2013,232:161–168.CrossRefPubMedGoogle Scholar
  96. 96.
    Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, et al. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 2010,124:164–169.CrossRefPubMedGoogle Scholar
  97. 97.
    Dwivedi Y, Rizavi HS, Teppen T, Sasaki N, Chen H, Zhang H, et al. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology 2007,32:2338–2350.CrossRefPubMedGoogle Scholar
  98. 98.
    Dwivedi Y, Rizavi HS, Zhang H, Mondal AC, Roberts RC, Conley RR, et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 2009,65:319–328.CrossRefPubMedGoogle Scholar
  99. 99.
    Dwivedi Y, Rizavi HS, Conley RR, Pandey GN. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 2006,11:86–98.CrossRefPubMedGoogle Scholar
  100. 100.
    Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 2001,77:916–928.CrossRefPubMedGoogle Scholar
  101. 101.
    Barthas F, Humo M, Gilsbach R, Waltisperger E, Karatas M, Leman S, et al. Cingulate Overexpression of Mitogen-Activated Protein Kinase Phosphatase-1 as a Key Factor for Depression. Biol Psychiatry 2017,82:370–379.CrossRefPubMedGoogle Scholar
  102. 102.
    Marsden WN. Synaptic plasticity in depression: Molecular, cellular and functional correlates. Progress In Neuro-Psychopharmacology & Biological Psychiatry 2013,43:168–184.CrossRefGoogle Scholar
  103. 103.
    First M, Gil-Ad I, Taler M, Tarasenko I, Novak N, Weizman A. The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci 2011,45:246–255.CrossRefPubMedGoogle Scholar
  104. 104.
    Qi X, Lin W, Wang D, Pan Y, Wang W, Sun M. A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 2009,199:203–209.CrossRefPubMedGoogle Scholar
  105. 105.
    Qi XL, Lin WJ, Li JF, Pan YQ, Wang WW. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behavioural Brain Research 2006,175:233–240.CrossRefPubMedGoogle Scholar
  106. 106.
    Reus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, et al. MAPK signaling correlates with the antidepressant effects of ketamine. J Psychiatr Res 2014,55:15–21.CrossRefPubMedGoogle Scholar
  107. 107.
    Pochwat B, Rafalo-Ulinska A, Domin H, Misztak P, Nowak G, Szewczyk B. Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats. Neuropharmacology 2017,125:333–342.CrossRefPubMedGoogle Scholar
  108. 108.
    Labonte B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, et al. Sex-specific transcriptional signatures in human depression. Nat Med 2017,23:1102–1111.CrossRefPubMedPubMedCentralGoogle Scholar
  109. 109.
    Quan MN, Zhang N, Wang YY, Zhang T, Yang Z. Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model. Neuroscience 2011,182:88–97.CrossRefPubMedGoogle Scholar
  110. 110.
    Covington HE, 3rd, Vialou V, Nestler EJ. From synapse to nucleus: novel targets for treating depression. Neuropharmacology 2010,58:683–693.CrossRefPubMedGoogle Scholar
  111. 111.
    Mailliet F, Qi H, Rocher C, Spedding M, Svenningsson P, Jay TM. Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling. Exp Neurol 2008,211:593–596.CrossRefPubMedGoogle Scholar
  112. 112.
    Pflug B, Tolle R. Disturbance of the 24-hour rhythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry 1971,6:187–196.CrossRefPubMedGoogle Scholar
  113. 113.
    Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998,93:929–937.CrossRefPubMedGoogle Scholar
  114. 114.
    Thompson CL, Wisor JP, Lee CK, Pathak SD, Gerashchenko D, Smith KA, et al. Molecular and anatomical signatures of sleep deprivation in the mouse brain. Front Neurosci 2010,4:165.CrossRefPubMedPubMedCentralGoogle Scholar
  115. 115.
    Wisor JP, Pasumarthi RK, Gerashchenko D, Thompson CL, Pathak S, Sancar A, et al. Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains (vol 28, pg 7193, 2008). J Neurosci 2008,28:7929–7929.CrossRefGoogle Scholar
  116. 116.
    Wisorl JP, O’Hara BF, Terao A, Selby CP, Kilduff TS, Sancar A, et al. A role for cryptochromes in sleep regulation. Bmc Neuroscience 2002,3.Google Scholar
  117. 117.
    Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C, et al. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci U S A 2007,104:20090–20095.CrossRefPubMedPubMedCentralGoogle Scholar
  118. 118.
    Zagaar M, Dao A, Levine A, Alhaider I, Alkadhi K. Regular exercise prevents sleep deprivation associated impairment of long-term memory and synaptic plasticity in the CA1 area of the hippocampus. Sleep 2013,36:751–761.CrossRefPubMedPubMedCentralGoogle Scholar
  119. 119.
    Serchov T, Clement HW, Schwarz MK, Iasevoli F, Tosh DK, Idzko M, et al. Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a. Neuron 2015,87:549–562.CrossRefPubMedPubMedCentralGoogle Scholar
  120. 120.
    Hines DJ, Schmitt LI, Hines RM, Moss SJ, Haydon PG. Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl Psychiatry 2013,3:e212.CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 2014,15:443–454.CrossRefPubMedPubMedCentralGoogle Scholar
  122. 122.
    Li X, Li X. The antidepressant effect of light therapy from retinal projections. Neurosci Bull 2018,34:359–368.CrossRefPubMedGoogle Scholar
  123. 123.
    Duncan WC, Jr., Slonena E, Hejazi NS, Brutsche N, Yu KC, Park L, et al. Motor-activity markers of circadian timekeeping are related to ketamine’s rapid antidepressant properties. Biol Psychiatry 2017.Google Scholar
  124. 124.
    Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One 2011,6:e23982.CrossRefPubMedPubMedCentralGoogle Scholar
  125. 125.
    Ma Z, Zang T, Birnbaum SG, Wang Z, Johnson JE, Zhang CL, et al. TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response. Nat Commun 2017,8:1668.CrossRefPubMedPubMedCentralGoogle Scholar
  126. 126.
    Yang C, Ren Q, Qu YG, Zhang JC, Ma M, Dong C, et al. Mechanistic target of rapamycin-independent antidepressant effects of (R)-Ketamine in a social defeat stress model. Biol Psychiatry 2018,83:18–28.CrossRefPubMedGoogle Scholar
  127. 127.
    Orozco-Solis R, Montellier E, Aguilar-Arnal L, Sato S, Vawter MP, Bunney BG, et al. A circadian genomic signature common to ketamine and sleep deprivation in the anterior cingulate cortex. Biol Psychiatry 2017,82:351–360.CrossRefPubMedPubMedCentralGoogle Scholar
  128. 128.
    Lazzerini Ospri L, Prusky G, Hattar S. Mood, the circadian system, and melanopsin retinal ganglion cells. Annu Rev Neurosci 2017,40:539–556.CrossRefPubMedGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS 2019

Authors and Affiliations

  1. 1.Savaid Medical SchoolUniversity of the Chinese Academy of SciencesBeijingChina
  2. 2.Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain ResearchPeking UniversityBeijingChina
  3. 3.National Institute on Drug Dependence and Beijing Key Laboratory on Drug Dependence ResearchPeking UniversityBeijingChina
  4. 4.Key Laboratory of Pathogenic Microbiology and Immunology, Institute of MicrobiologyChinese Academy of SciencesBeijingChina
  5. 5.Chinese Center for Disease Control and PreventionBeijingChina
  6. 6.Institute of Mental Health, National Clinical Research Center for Mental Disorders, Key Laboratory of Mental Health and Peking University Sixth HospitalPeking UniversityBeijingChina

Personalised recommendations